ACTIVE HALF-LIFE
A Few Minutes
CLASSIFICATION
?-Melanocyte-Stimulating Hormone Analog
DOSAGE
5 mg/day
ACNE
Not Present
WATER RETENTION
None
HBR
Absent
HEPATOTOXICITY
Not Applicable
AROMATIZATION
No
MANUFACTURER
Beligas
WAREHOUSE
International Warehouse 3
SUBSTANCE
Melanocyte-Stimulating Hormone (MSH)
Introducing Melanotan 1, a cutting-edge synthetic version of the melanocyte-stimulating hormone (?-MSH) designed to enhance skin pigmentation through the stimulation of melanogenesis?the body's natural process of melanin production. Melanin acts as a protective shield for skin cells, absorbing and reflecting harmful UV light to prevent cellular damage. By facilitating the creation of dark protective melanin, Melanotan significantly minimizes sun damage to skin exposed to UV radiation.
Melanotan Dosage:
The recommended dosage ranges from 250 mcg to 2 mg.
Melanotan Results:
This innovative peptide encourages the production of eumelanin (the darker hue) over pheomelanin, allowing you to achieve enhanced tanning results that exceed normal physiological levels when using Melanotan 1.
Research Use:
Melanotan peptides, with their short half-life, are being explored for applications in dermatology, including the development of afamelanotide implants that release the peptide over time, effectively impacting melanin density for several months. Melanotan 1 can be conveniently purchased online in research peptide form for regular low-dose subcutaneous injections.
Lifestyle:
Melanocortins are poised to revolutionize cosmetic treatments, similar to the breakthroughs of Viagra and Botox. Melanotan can be used continuously or intermittently based on your preferences.
Recommended Therapy:
Intermittent therapy durations can vary from 10 days for skin type III to up to 6 months for skin type I. Monitoring melanin density post-administration is crucial for optimal results.
Peptide Molecule:
The production of Melanotan 1 involves modifications to two amino acids in the body?s natural ?-MSH, enhancing its stability and effectiveness through subcutaneous injection.
Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2
Amino Acid Sequence:
Clinical Trial:
Currently, Melanotan is in the clinical trial phase and remains unapproved for general use. Users are advised that it is intended for research purposes only. Mild nausea and flushing may occur after subcutaneous injection, but these effects are typically short-lived.
Administration of Research Melanotan:
Safe and regulated administration of afamelanotide for research resembles that of Melanotan 2. Melanotan 1 is available in multi-dose sterile vials, while other forms like implants, nasal sprays, or pills are not currently recognized as effective.
It?s important to note that Melanotan 1 requires a higher dosage?8 to 10 times more than Melanotan 2?to achieve comparable tanning results. Users of Melanotan 1 seek minimal side effects while prioritizing photoprotection, so patience and preparation are essential throughout the Melanotan journey.
Melanotan therapy can help users cultivate a protective tan, as natural tanning occurs in response to UV-induced cellular damage. Ultraviolet rays penetrate the skin, activating ?-MSH and stimulating melanin production, which acts as a natural sunblock. With Melanotan injections, you can achieve a cosmetic tan while minimizing skin damage.
Please remember that the information provided here is not a substitute for professional medical advice and is not intended for the diagnosis, treatment, cure, or prevention of any disease.